Quanterix Corporation Tax Withholding Paid on Stock Awards
Quanterix Corporation (QTRX) reported Tax Withholding Paid on Stock Awards of $27.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-10
- Quanterix Corporation payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Quanterix Corporation payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $27.00K, a 95.30% decline year-over-year.
- Quanterix Corporation payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $436.00K, a 1576.92% increase year-over-year.
- Quanterix Corporation payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $6.00K, a 98.62% decline year-over-year.
- Quanterix Corporation payment, tax withholding, share-based payment arrangement for fiscal 2025 was $1.45M, a 44.60% decline from fiscal 2024.
- Quanterix Corporation payment, tax withholding, share-based payment arrangement for fiscal 2024 was $2.61M, a 1218.18% increase from fiscal 2023.
- Quanterix Corporation payment, tax withholding, share-based payment arrangement for fiscal 2023 was $198.00K.
- Quanterix Corporation payment, tax withholding, share-based payment arrangement for fiscal 2022 was $0.00.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $27.00K 10-Q · filed 2026-08-10 | $463.00K derived: sum of 3 quarters · filed 2026-08-10 | $469.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $27.00K 10-Q · filed 2026-05-06 | $463.00K derived: sum of 2 quarters · filed 2026-05-06 | $469.00K derived: sum of 3 quarters · filed 2026-05-06 | $898.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $436.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $442.00K derived: sum of 2 quarters · filed 2026-03-02 | $871.00K derived: sum of 3 quarters · filed 2026-08-10 | $1.45M 10-K · filed 2026-03-02 |
| 2025-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $435.00K derived: sum of 2 quarters · filed 2026-08-10 | $1.01M 10-Q · filed 2025-11-10 | $1.04M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $429.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.00M 10-Q · filed 2026-08-10 | $1.03M derived: sum of 3 quarters · filed 2026-08-10 | $1.46M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $575.00K 10-Q · filed 2026-05-06 | $601.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.03M derived: sum of 3 quarters · filed 2026-05-06 | $1.75M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $460.00K derived: sum of 2 quarters · filed 2026-03-02 | $1.17M derived: sum of 3 quarters · filed 2026-03-02 | $2.61M 10-K · filed 2026-03-02 |
| 2024-09-30 | $434.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.15M derived: sum of 2 quarters · filed 2025-11-10 | $2.58M 10-Q · filed 2025-11-10 | $2.64M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $712.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.15M 10-Q · filed 2025-08-07 | $2.21M derived: sum of 3 quarters · filed 2026-03-02 | $2.26M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $1.44M 10-Q · filed 2025-05-12 | $1.49M derived: sum of 2 quarters · filed 2026-03-02 | $1.55M derived: sum of 3 quarters · filed 2026-03-02 | $1.62M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $56.00K derived: 10-K 12 month − 10-K/A 9 month · filed 2026-03-02 | $111.00K derived: sum of 2 quarters · filed 2026-03-02 | $185.00K derived: sum of 3 quarters · filed 2026-03-02 | $198.00K 10-K · filed 2026-03-02 |
| 2023-09-30 | $55.00K derived: 10-K/A 9 month − 10-K/A 6 month · filed 2024-12-26 | $129.00K derived: sum of 2 quarters · filed 2024-12-26 | $142.00K 10-K/A · filed 2024-12-26 | |
| 2023-06-30 | $74.00K derived: 10-K/A 6 month − 10-K/A 3 month · filed 2024-12-26 | $87.00K 10-K/A · filed 2024-12-26 | ||
| 2023-03-31 | $13.00K 10-K/A · filed 2024-12-26 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-03-17 | |||
| 2021-12-31 | $0.00 10-K/A · filed 2024-12-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |